Takeda Pharmaceutical Company Limited Stock NYSE
Stocks
TAK
US8740602052
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.96 USD | +0.41% |
|
+5.80% | +8.79% |
| 07-02 | Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading | MT |
| 07-02 | Takeda, Insilico Sign AI-Driven Drug Discovery Pact | MT |
| Market Cap | 8,607B 53.16B 46.52B 42.88B 39.74B 75.44B 5,046B 76.66B 514B 200B 2,490B 200B 195B | P/E 2027 * |
44.3x | P/E 2028 * | 28.4x |
|---|---|---|---|---|---|
| Enterprise Value | 12,493B 77.16B 67.53B 62.23B 57.68B 109B 7,324B 111B 746B 290B 3,614B 290B 283B | EV / Sales 2027 * |
2.7x | EV / Sales 2028 * | 2.63x |
| Free-Float |
99.25% | Yield 2027 * |
3.75% | Yield 2028 * | 3.82% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +0.41% | ||
| 1 week | +5.80% | ||
| Current month | +5.80% | ||
| 1 month | +8.72% | ||
| 3 months | -7.27% | ||
| 6 months | +6.67% | ||
| Current year | +8.79% |
| 1 week | 16.42 |  | 17.12 |
| 1 month | 15.34 | | 17.12 |
| Current year | 14.84 | | 18.9 |
| 1 year | 12.99 | | 18.9 |
| 3 years | 12.58 | | 18.9 |
| 5 years | 12.28 | | 18.9 |
| 10 years | 12.28 | | 31.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2026-06-23 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 2024-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 2022-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 2015-05-31 |
Steven Gillis
BRD | Director/Board Member | 73 | 2018-12-31 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 2024-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.41% | +5.80% | - | - | 53.16B | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,102B | |
| +3.05% | +5.23% | +72.11% | +67.81% | 643B | |
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | |
| -2.58% | -2.07% | +27.62% | +22.57% | 336B | |
| +1.36% | +0.17% | +29.90% | +49.33% | 288B | |
| +1.98% | +4.08% | -25.78% | -39.02% | 222B | |
| +0.45% | +1.65% | +25.65% | +68.35% | 199B | |
| +5.21% | +7.93% | +21.99% | +83.23% | 169B | |
| +1.48% | -0.04% | -4.64% | -32.25% | 137B | |
| Average | +0.81% | +2.00% | +26.94% | +53.47% | 393.9B | |
| Weighted average by Cap. | +1.49% | +1.86% | +41.96% | +87.59% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,630B 28.6B 25.03B 23.07B 21.38B 40.58B 2,714B 41.24B 277B 108B 1,340B 107B 105B | 4,701B 29.04B 25.41B 23.42B 21.7B 41.2B 2,756B 41.87B 281B 109B 1,360B 109B 107B |
| Net income | 184B 1.14B 994M 916M 849M 1.61B 108B 1.64B 10.98B 4.27B 53.2B 4.26B 4.17B | 309B 1.91B 1.67B 1.54B 1.43B 2.71B 181B 2.75B 18.48B 7.18B 89.49B 7.17B 7.02B |
| Net Debt | 3,886B 24B 21B 19.36B 17.94B 34.06B 2,278B 34.61B 232B 90.26B 1,124B 90.1B 88.15B | 3,750B 23.17B 20.27B 18.68B 17.32B 32.87B 2,199B 33.4B 224B 87.12B 1,085B 86.97B 85.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | US$16.96 | +0.41% | 2,654,300 |
| 26-07-06 | US$16.89 | +0.72% | 2,883,396 |
| 26-07-02 | US$16.77 | +5.14% | 3,515,152 |
| 26-07-01 | US$15.95 | -0.50% | 2,169,571 |
| 26-06-30 | US$16.03 | +0.31% | 2,948,737 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- TAK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
